JP2023504190A5 - - Google Patents
Info
- Publication number
- JP2023504190A5 JP2023504190A5 JP2022533105A JP2022533105A JP2023504190A5 JP 2023504190 A5 JP2023504190 A5 JP 2023504190A5 JP 2022533105 A JP2022533105 A JP 2022533105A JP 2022533105 A JP2022533105 A JP 2022533105A JP 2023504190 A5 JP2023504190 A5 JP 2023504190A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- microparticles
- grna molecule
- lipid nanoparticles
- nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962943093P | 2019-12-03 | 2019-12-03 | |
| US62/943,093 | 2019-12-03 | ||
| PCT/US2020/063150 WO2021113536A1 (en) | 2019-12-03 | 2020-12-03 | Systems and methods for lipid nanoparticle delivery of gene editing machinery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504190A JP2023504190A (ja) | 2023-02-01 |
| JP2023504190A5 true JP2023504190A5 (enExample) | 2023-12-12 |
Family
ID=76222327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533105A Pending JP2023504190A (ja) | 2019-12-03 | 2020-12-03 | 遺伝子編集機構の脂質ナノ粒子送達のためのシステムおよび方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230032846A1 (enExample) |
| EP (1) | EP4069314A4 (enExample) |
| JP (1) | JP2023504190A (enExample) |
| AR (1) | AR122347A1 (enExample) |
| WO (1) | WO2021113536A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013163628A2 (en) | 2012-04-27 | 2013-10-31 | Duke University | Genetic correction of mutated genes |
| US9828582B2 (en) | 2013-03-19 | 2017-11-28 | Duke University | Compositions and methods for the induction and tuning of gene expression |
| JP6929791B2 (ja) | 2015-02-09 | 2021-09-01 | デューク ユニバーシティ | エピゲノム編集のための組成物および方法 |
| WO2017035416A2 (en) | 2015-08-25 | 2017-03-02 | Duke University | Compositions and methods of improving specificity in genomic engineering using rna-guided endonucleases |
| EP4089175A1 (en) | 2015-10-13 | 2022-11-16 | Duke University | Genome engineering with type i crispr systems in eukaryotic cells |
| WO2017095967A2 (en) | 2015-11-30 | 2017-06-08 | Duke University | Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use |
| EP3443081A4 (en) | 2016-04-13 | 2019-10-30 | Duke University | CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE |
| EP4275747A3 (en) | 2016-07-19 | 2024-01-24 | Duke University | Therapeutic applications of cpf1-based genome editing |
| US12509492B2 (en) | 2018-01-19 | 2025-12-30 | Duke University | Genome engineering with CRISPR-Cas systems in eukaryotes |
| KR20250044484A (ko) | 2022-06-24 | 2025-03-31 | 튠 쎄라퓨틱스, 인코포레이티드 | 표적 유전자 억제를 통해 저밀도 지단백질을 감소시키기 위한 조성물, 시스템, 및 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3029138T3 (en) * | 2013-06-05 | 2025-06-23 | Univ Duke | Rna-guided gene editing and gene regulation |
| AU2016344609B2 (en) * | 2015-10-28 | 2022-05-12 | Vertex Pharmaceuticals Incorporated | Materials and methods for treatment of duchenne muscular dystrophy |
| ES2957660T3 (es) * | 2016-05-05 | 2024-01-23 | Univ Duke | Composiciones relacionadas con crispr/cas para tratar la distrofia muscular de duchenne |
| US20210032622A1 (en) * | 2017-11-09 | 2021-02-04 | Crispr Therapeutics Ag | Self-inactivating (sin) crispr/cas or crispr/cpf1 systems and uses thereof |
| KR20200116933A (ko) * | 2018-01-31 | 2020-10-13 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 인간 심근세포에서 디스트로핀 돌연변이를 교정하기 위한 조성물 및 방법 |
-
2020
- 2020-12-03 WO PCT/US2020/063150 patent/WO2021113536A1/en not_active Ceased
- 2020-12-03 EP EP20895944.5A patent/EP4069314A4/en active Pending
- 2020-12-03 US US17/782,112 patent/US20230032846A1/en active Pending
- 2020-12-03 JP JP2022533105A patent/JP2023504190A/ja active Pending
- 2020-12-03 AR ARP200103372A patent/AR122347A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11492670B2 (en) | Compositions and methods for targeting cancer-specific sequence variations | |
| CN107406854B (zh) | Rna指导的人类jc病毒和其他多瘤病毒的根除 | |
| JP7810442B2 (ja) | 機能的ミエリン産生を増進させるための方法および組成物 | |
| US20210054370A1 (en) | Methods and compositions for treating angelman syndrome | |
| CN118910166A (zh) | 调节性多核苷酸 | |
| US20170088839A1 (en) | Dna aptamers for promoting remyelination | |
| JP2018509909A5 (enExample) | ||
| CN116334086A (zh) | 一种用于修复或抑制SCN1A基因异常剪接的U1-snRNA及其用途 | |
| CN116096886A (zh) | 用于调节叉头框p3(foxp3)基因表达的组合物和方法 | |
| Bansal et al. | CRISPR Cas9 based genome editing in inherited retinal dystrophies | |
| US20220378942A1 (en) | Compositions and methods for treating alzheimer's disease | |
| US20250161488A1 (en) | THERAPEUTIC mRNA | |
| JP2020528735A (ja) | 反復伸長変異のためのゲノム編集システム | |
| TW201918556A (zh) | 用於細胞重編程之方法及組合物 | |
| US20220290157A1 (en) | Compositions and methods for treating amyotrophic lateral sclerosis | |
| JP2007501601A5 (enExample) | ||
| CN116640763A (zh) | 一种治疗Dravet综合征或其他难治性癫痫的U7-snRNA及其用途 | |
| Stieger et al. | RPE and gene therapy | |
| Xu et al. | Gene Therapy for Hereditary Hearing Loss: Comprehensive Overview and Clinical Applications | |
| TW202610664A (zh) | 通過表觀編輯靶向調節pcsk9的方法及其用途 | |
| WO2025261493A1 (zh) | 通过表观编辑靶向调节pcsk9的方法及其用途 | |
| KR20240027748A (ko) | Rbm20 돌연변이의 게놈 편집 | |
| TW202606727A (zh) | 靶向抑制素亞基βＥ（ＩＮＨＢＥ）的工程化基因轉錄阻抑工具及其用途 | |
| HK40105680A (en) | Methods and compositions for enhancing functional myelin production | |
| LLADO SANTAEULARIA | THERAPEUTIC GENOME EDITING IN RETINA AND LIVER |